Preliminary Q4 2021 Redx Pharma PLC Earnings Call Transcript
(technical difficulty) I'd like to advise all parties this conference is being recorded. I will now hand it over to Rachel Curtis Gravesen to open the call.
Hello, and welcome, and thank you so much for joining us for today's call to discuss Redx's full year results for the year ended September 30, 2021. In a moment, I'm going to hand over to Redx's Chief Executive Officer, Lisa Anson, who'll be joined by Chief Financial Officer, Peter Collum, and also Chief Scientific Officer, Richard Armer, who are going to present the progress made during this year by the company.
After the presentation, we will hold a question-and-answer session. And we'll be joined by Dr. Jane Robertson, the company's CMO, who's going to participate in that session together with the other presenters that we've just named. (Operator Instructions)
Please, let's move to the next slide. Importantly, I'd like to say before we begin that I want to draw your attention to the disclaimer slide that we have in front of you here and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
